Nicole Kopinski of the Leydig Chicago office will be speaking on a panel at AIPLA’s Advanced Chemical/Pharma Patent Practice Institute on May 20, 2022 in New Orleans. Her topic will be “Objective Evidence: Rebutting a Prima Facie Case of Obviousness.”
News
